A detailed history of Longfellow Investment Management CO LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Longfellow Investment Management CO LLC holds 150,896 shares of BMY stock, worth $8.72 Million. This represents 1.96% of its overall portfolio holdings.

Number of Shares
150,896
Previous 150,657 0.16%
Holding current value
$8.72 Million
Previous $6.26 Million 24.81%
% of portfolio
1.96%
Previous 1.57%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$39.66 - $51.75 $9,478 - $12,368
239 Added 0.16%
150,896 $7.81 Million
Q2 2024

Aug 07, 2024

BUY
$40.25 - $52.99 $4.82 Million - $6.34 Million
119,681 Added 386.37%
150,657 $6.26 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $293,013 - $332,220
6,107 Added 24.56%
30,976 $1.68 Million
Q3 2023

Nov 09, 2023

BUY
$57.89 - $64.73 $152,482 - $170,498
2,634 Added 11.85%
24,869 $1.44 Million
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $57,593 - $63,948
904 Added 4.24%
22,235 $1.42 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $704,214 - $798,738
10,717 Added 100.97%
21,331 $1.48 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $1.12 Million - $1.23 Million
-15,429 Reduced 59.24%
10,614 $818,000
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $116,377 - $135,668
2,170 Added 9.09%
26,043 $1.62 Million
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $602,941 - $656,603
-9,739 Reduced 28.97%
23,873 $1.6 Million
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $144,670 - $162,712
2,438 Added 7.82%
33,612 $2.12 Million
Q4 2020

Feb 16, 2021

BUY
$57.74 - $65.43 $1.8 Million - $2.04 Million
31,174 New
31,174 $1.93 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Longfellow Investment Management CO LLC Portfolio

Follow Longfellow Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Longfellow Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Longfellow Investment Management CO LLC with notifications on news.